Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -347.04% |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 73.00% |
| 10 | Tarsus Pharmaceuticals | 2.60 Bn | 2.50 Bn | 152.66 Mn | 75.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.77% |
| Dec 31, 2025 | 65.17% |
| Sep 30, 2025 | 37.75% |
| Jun 30, 2025 | 98.67% |
| Mar 31, 2025 | 69.02% |
| Dec 31, 2024 | 76.99% |
| Sep 30, 2024 | 78.43% |
| Jun 30, 2024 | 60.79% |
| Mar 31, 2024 | -5.09% |
| Dec 31, 2023 | 49.87% |
| Sep 30, 2023 | -31.84% |
| Jun 30, 2023 | -319.36% |
| Mar 31, 2023 | 40.95% |
| Jun 30, 2022 | -110.95% |
| Mar 31, 2022 | -157.08% |
| Dec 31, 2020 | 99.43% |